Koninklijke Philips Current Ratio 2011-2025 | PHG
Current and historical current ratio for Koninklijke Philips (PHG) from 2011 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Koninklijke Philips current ratio for the three months ending June 30, 2025 was 1.26.
| Koninklijke Philips Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $10.29B | $8.18B | 1.26 |
| 2025-03-31 | $9.13B | $7.12B | 1.28 |
| 2024-09-30 | $0.00B | 0.00 | |
| 2024-06-30 | $10.92B | $9.44B | 1.16 |
| 2023-06-30 | $10.56B | $8.80B | 1.20 |
| 2023-03-31 | $0.00B | 0.00 | |
| 2022-06-30 | $10.68B | $8.97B | 1.19 |
| 2021-06-30 | $11.36B | $10.57B | 1.08 |
| 2020-06-30 | $10.99B | $8.25B | 1.33 |
| 2019-06-30 | $10.20B | $8.01B | 1.27 |
| 2018-06-30 | $10.81B | $8.50B | 1.27 |
| 2017-06-30 | $17.05B | $11.42B | 1.49 |
| 2016-12-31 | $15.58B | $11.59B | 1.34 |
| 2016-09-30 | $14.78B | $10.23B | 1.45 |
| 2016-06-30 | $14.99B | $10.02B | 1.50 |
| 2016-03-31 | $13.39B | $10.86B | 1.23 |
| 2015-12-31 | $14.09B | $11.18B | 1.26 |
| 2015-09-30 | $13.72B | $10.75B | 1.28 |
| 2015-06-30 | $13.78B | $11.05B | 1.25 |
| 2015-03-31 | $14.85B | $12.00B | 1.24 |
| 2014-12-31 | $16.49B | $12.27B | 1.35 |
| 2014-09-30 | $15.63B | $12.49B | 1.25 |
| 2014-06-30 | $14.44B | $11.30B | 1.28 |
| 2014-03-31 | $14.98B | $11.24B | 1.33 |
| 2013-12-31 | $15.24B | $11.26B | 1.35 |
| 2013-09-30 | $15.42B | $12.10B | 1.28 |
| 2013-06-30 | $14.91B | $12.30B | 1.21 |
| 2013-03-31 | $15.96B | $12.99B | 1.23 |
| 2012-12-31 | $16.11B | $12.80B | 1.26 |
| 2012-09-30 | $15.34B | $11.40B | 1.35 |
| 2012-06-30 | $15.45B | $11.46B | 1.35 |
| 2012-03-31 | $17.30B | $12.35B | 1.40 |
| 2011-12-31 | $17.38B | $13.01B | 1.34 |
| 2011-09-30 | $16.92B | $11.83B | 1.43 |
| 2011-06-30 | $17.48B | $11.46B | 1.53 |
| 2011-03-31 | $18.43B | $13.32B | 1.38 |
| 2010-12-31 | $19.39B | $14.29B | 1.36 |
| 2010-09-30 | $17.23B | $12.82B | 1.34 |
| 2010-06-30 | $17.25B | $13.83B | 1.25 |
| 2010-03-31 | $17.18B | $12.88B | 1.33 |
| 2009-12-31 | $16.61B | $11.23B | 1.48 |
| 2009-09-30 | $17.06B | $12.41B | 1.37 |
| 2009-06-30 | $15.31B | $10.87B | 1.41 |
| 2009-03-31 | $15.56B | $11.51B | 1.35 |
| 2008-12-31 | $18.93B | $13.13B | 1.44 |
| 2008-09-30 | $19.48B | $12.90B | 1.51 |
| 2008-06-30 | $19.59B | $11.68B | 1.68 |
| 2008-03-31 | $22.01B | $14.94B | 1.47 |
| 2007-12-31 | $24.45B | $13.21B | 1.85 |
| 2007-09-30 | $20.62B | $13.67B | 1.51 |
| 2007-06-30 | $20.88B | $13.08B | 1.60 |
| 2007-03-31 | $19.29B | $11.88B | 1.62 |
| 2006-12-31 | $18.79B | $11.47B | 1.64 |
| 2006-09-30 | $21.30B | $12.10B | 1.76 |
| 2006-06-30 | $15.82B | $12.34B | 1.28 |
| 2006-03-31 | $16.42B | $13.05B | 1.26 |
| 2005-12-31 | $18.81B | $12.92B | 1.46 |
| 2005-09-30 | $17.71B | $11.55B | 1.53 |
| 2005-06-30 | $16.24B | $11.06B | 1.47 |
| 2005-03-31 | $16.06B | $11.82B | 1.36 |
| 2004-12-31 | $18.03B | $12.42B | 1.45 |
| 2004-09-30 | $14.39B | $11.40B | 1.26 |
| 2004-06-30 | $14.50B | $11.95B | 1.21 |
| 2004-03-31 | $15.36B | $12.83B | 1.20 |
| 2003-12-31 | $14.49B | $11.64B | 1.25 |
| 2003-09-30 | $11.84B | $11.25B | 1.05 |
| 2003-06-30 | $12.51B | $10.78B | 1.16 |
| 2003-03-31 | $11.80B | $9.96B | 1.19 |
| 2002-12-31 | $11.59B | $9.57B | 1.21 |
| 2002-09-30 | $11.11B | $7.81B | 1.42 |
| 2002-06-30 | $11.22B | $7.41B | 1.51 |
| 2002-03-31 | $10.80B | $7.52B | 1.44 |
| 2001-12-31 | $10.16B | $9.68B | 1.05 |
| 2001-09-30 | $10.61B | $13.21B | 0.80 |
| 2001-06-30 | $11.42B | $12.45B | 0.92 |
| 2001-03-31 | $12.44B | $13.01B | 0.96 |
| 2000-12-31 | $12.41B | $10.77B | 1.15 |
| 2000-09-30 | $15.11B | $11.66B | 1.30 |
| 2000-06-30 | $16.58B | $7.83B | 2.12 |
| 2000-03-31 | $15.30B | $8.50B | 1.80 |
| 1999-12-31 | $15.02B | $9.70B | 1.55 |
| 1999-09-30 | $13.85B | $7.57B | 1.83 |
| 1999-06-30 | $15.44B | $7.28B | 2.12 |
| 1999-03-31 | $19.20B | $7.75B | 2.48 |
| 1998-12-31 | $18.11B | $9.91B | 1.83 |
| 1998-09-30 | $0.00B | 0.00 | |
| 1998-06-30 | $0.00B | 0.00 | |
| 1998-03-31 | $0.00B | 0.00 | |
| 1997-12-31 | $16.17B | $12.25B | 1.32 |
| 1997-09-30 | $0.00B | 0.00 | |
| 1997-06-30 | $0.00B | 0.00 | |
| 1997-03-31 | $0.00B | 0.00 | |
| 1996-12-31 | $19.14B | $13.35B | 1.43 |
| 1996-09-30 | $0.00B | 0.00 | |
| 1996-06-30 | $0.00B | 0.00 | |
| 1996-03-31 | $0.00B | 0.00 | |
| 1995-12-31 | $19.90B | $12.79B | 1.56 |
| 1995-09-30 | $0.00B | 0.00 | |
| 1995-06-30 | $0.00B | 0.00 | |
| 1995-03-31 | $0.00B | 0.00 | |
| 1994-12-31 | $8.91B | $5.49B | 1.62 |
| 1994-09-30 | $0.00B | 0.00 | |
| 1994-06-30 | $0.00B | 0.00 | |
| 1994-03-31 | $0.00B | 0.00 | |
| 1993-12-31 | $13.11B | $10.74B | 1.22 |
| 1993-09-30 | $0.00B | 0.00 | |
| 1992-12-31 | $0.00B | 0.00 | |
| 1990-12-31 | $14.56B | $10.76B | 1.35 |
| 1989-12-31 | $13.71B | $9.97B | 1.38 |
| 1988-12-31 | $14.02B | $9.53B | 1.47 |
| 1987-12-31 | $12.92B | $9.02B | 1.43 |
| 1986-12-31 | $0.19B | $0.19B | 1.00 |
| 1986-06-30 | $0.00B | 0.00 | |
| 1986-03-31 | $0.00B | 0.00 | |
| 1985-12-31 | $0.14B | $0.14B | 1.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $27.848B | $19.503B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.767B | 25.90 |
| EssilorLuxottica (ESLOY) | France | $171.623B | 0.00 |
| Boston Scientific (BSX) | United States | $155.627B | 35.59 |
| Stryker (SYK) | United States | $142.805B | 28.35 |
| Medtronic (MDT) | Ireland | $123.317B | 17.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.676B | 0.00 |
| Agilent Technologies (A) | United States | $41.643B | 26.95 |
| ResMed (RMD) | United States | $36.793B | 25.47 |
| GE HealthCare Technologies (GEHC) | United States | $33.695B | 16.11 |
| Insulet (PODD) | United States | $23.402B | 72.64 |
| Terumo (TRUMY) | Japan | $22.490B | 25.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.949B | 11.19 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.072B | 0.00 |
| Baxter (BAX) | United States | $9.613B | 7.76 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.548B | 30.74 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.522B | 10.73 |
| Haemonetics (HAE) | United States | $3.460B | 15.40 |
| ICU Medical (ICUI) | United States | $3.420B | 21.71 |
| Envista Holdings (NVST) | United States | $3.270B | 18.76 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.885B | 13.16 |
| LeMaitre Vascular (LMAT) | United States | $2.034B | 40.93 |
| Perrigo (PRGO) | Ireland | $1.923B | 4.82 |
| Phibro Animal Health (PAHC) | United States | $1.812B | 18.10 |
| Curaleaf Holdings (CURLF) | Canada | $1.735B | 0.00 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.507B | 9.69 |
| Neogen (NEOG) | United States | $1.384B | 26.54 |
| Green Thumb Industries (GTBIF) | United States | $1.379B | 60.46 |
| Kestra Medical Technologies (KMTS) | United States | $1.282B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.269B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 18.29 |
| BioLife Solutions (BLFS) | United States | $1.210B | 359.14 |
| InMode (INMD) | Israel | $0.904B | 10.21 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.794B | 0.00 |
| Surmodics (SRDX) | United States | $0.592B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.499B | 17.17 |
| Evolus (EOLS) | United States | $0.478B | 0.00 |
| CeriBell (CBLL) | United States | $0.463B | 0.00 |
| SNDL (SNDL) | Canada | $0.447B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.427B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.307B | 0.00 |
| Brainsway (BWAY) | Israel | $0.304B | 53.37 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.264B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.264B | 0.00 |
| High Tide (HITI) | Canada | $0.250B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 146.33 |
| Quanterix (QTRX) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.244B | 19.42 |
| Owens & Minor (OMI) | United States | $0.227B | 2.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.191B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 15.85 |
| Sanara MedTech (SMTI) | United States | $0.175B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.33 |
| OraSure Technologies (OSUR) | United States | $0.164B | 0.00 |
| Apyx Medical (APYX) | United States | $0.156B | 0.00 |
| Biote (BTMD) | United States | $0.119B | 5.20 |
| Jushi Holdings (JUSHF) | United States | $0.106B | 0.00 |
| MacroGenics (MGNX) | United States | $0.101B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 13.27 |
| Sharps Technology (STSS) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 23.27 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.030B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.35 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Zynex (ZYXI) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |